We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




MRI-Related Patents Issued to Biophan

By MedImaging staff writers
Posted on 02 Sep 2005
Biophan Technologies, Inc. More...
(Rochester, NY, USA) has two new U.S patents issued to the company, while one U.S. patent has been issued to Nanoset, LLC (East Rochester, NY, USA), a technology collaborator that has granted Biophan exclusive worldwide medical rights to the patent.

These newly issued patents increase Biophan's intellectual property portfolio to 144 U.S. patients, applications, or licenses. "These patents can provide improved capabilities to a wide variety of devices, increasing the technologies we have to offer,” said Michael Weiner, CEO of Biophan. "This fits with our strategy of providing enabling technology to many device manufacturers.”

One patent covers cardiac-assist devices designed to be compatible with magnetic resonance imaging (MRI), when MRI signals are detected, so that the communications circuit between the heart and the device can be interrupted, to avoid the possible hazards of tissue heating and induced voltages. Sensing the MRI unit's excitation signal by use of an opto-electronic device is covered by this patent. This is one of several approaches to address the problems of MRI safety and cardiac-assist devices such as defibrillators and pacemakers.

"In [another patent,] we teach how to convert electrical information, including radio waves, into optical signals to move them along an optical fiber, when used in conjunction with MRI,” Mr. Weiner added. "MRI provides the advantage of superior tissue imaging with no exposure to potentially harmful ionizing radiation. The technology also has potential applications for oncology, diabetes, and other diseases.”

The third patent covers almost any medical conductor, including a defibrillator, pacemaker, or neurostimulator lead, that includes nonmagnetic coatings and is designed to be flexible.

Biophan recently completed a licensing agreement and received an equity investment from Boston Scientific (Natick, MA, USA). Under the agreement, Boston Scientific receives specific licensing rights within certain product categories to these and other Biophan and Nanoset patents.



Related Links:
Biophan Technologies, Inc

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
New
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.